Addus HomeCare vs Lifestance Health
Add, change or remove companies; up to four.
The short version
- Lifestance Health is the larger business, with $1.4B of revenue in fiscal 2025 against $1.4B for Addus HomeCare.
- Addus HomeCare grew revenue faster (23.2%, against 13.9%).
- Addus HomeCare kept more of each dollar of sales as operating profit (9.7% operating margin, against 1.7%).
- Addus HomeCare earned a higher return on the capital invested in it (9.4%, against 1.2%).
- Investors pay more for each dollar of Lifestance Health’s earnings: a P/E of 99.5x against 21.3x for Addus HomeCare.
| Latest fiscal year | ADUS · FY25 | LFST · FY25 |
|---|---|---|
| Size | ||
| Market cap | $2.3B | $5.0B |
| Revenue | $1.4B | $1.4B |
| Free cash flow | $104M | $110M |
| Net income | $95.9M | $9.7M |
| Growth | ||
| Revenue growth | 23.2% | 13.9% |
| 5-year growth | 13.2% | 46.3% |
| Share count change | 5.8% | 3.2% |
| Profitability | ||
| Gross margin | 32.5% | — |
| Operating margin | 9.7% | 1.7% |
| Net margin | 6.7% | 0.7% |
| FCF margin | 7.3% | 7.7% |
| Return on capital | 9.4% | 1.2% |
| Return on equity | 9.3% | 0.7% |
| Balance sheet | ||
| Net debt | $39.4M | $34.2M |
| Net debt / EBITDA | 0.3x | 0.5x |
| Dividends and buybacks | $0.0M | $0.0M |
| Valuation & quality | ||
| P/E | 21.3x | 99.5x |
| Piotroski F-score | 5 | 7 |
Revenue
FY16
ADUS $401M
LFST —
FY17
ADUS $426M
LFST —
FY18
ADUS $517M
LFST —
FY19
ADUS $649M
LFST $213M
FY20
ADUS $765M
LFST —
FY21
ADUS $865M
LFST $668M
FY22
ADUS $951M
LFST $860M
FY23
ADUS $1.1B
LFST $1.1B
FY24
ADUS $1.2B
LFST $1.3B
FY25
ADUS $1.4B
LFST $1.4B
ADUS
LFST
Operating margin
FY16
ADUS 3.9%
LFST —
FY17
ADUS 5.9%
LFST —
FY18
ADUS 4.4%
LFST —
FY19
ADUS 5.4%
LFST 7.2%
FY20
ADUS 5.8%
LFST —
FY21
ADUS 7.6%
LFST −42.9%
FY22
ADUS 7.2%
LFST −24.5%
FY23
ADUS 8.6%
LFST −17.9%
FY24
ADUS 8.9%
LFST −2.5%
FY25
ADUS 9.7%
LFST 1.7%
ADUS
LFST
Free cash flow
FY16
ADUS −$2.5M
LFST —
FY17
ADUS $49.2M
LFST —
FY18
ADUS $27.9M
LFST —
FY19
ADUS $7.4M
LFST $2.7M
FY20
ADUS $103M
LFST —
FY21
ADUS $34.8M
LFST −$85.1M
FY22
ADUS $96.8M
LFST −$26.5M
FY23
ADUS $103M
LFST −$57.4M
FY24
ADUS $110M
LFST $85.7M
FY25
ADUS $104M
LFST $110M
ADUS
LFST
Return on capital
FY16
ADUS 7.4%
LFST —
FY17
ADUS 8.6%
LFST —
FY18
ADUS 9.7%
LFST —
FY19
ADUS 8.5%
LFST —
FY20
ADUS 7.1%
LFST —
FY21
ADUS 8.3%
LFST —
FY22
ADUS 8.0%
LFST −10.4%
FY23
ADUS 9.6%
LFST −9.1%
FY24
ADUS 8.2%
LFST −1.6%
FY25
ADUS 9.4%
LFST 1.2%
ADUS
LFST
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.